With an objective to efficiently regulate the medical devices under the Drugs and Cosmetics (D&C) Act in a phase-wise manner, CDSCO or the central Drugs Control Organization has advised four medical device testing laboratories to carry out the evaluation of the medical devices.
Central Government entitles different labs as Central Medical
Device Testing Laboratory under MDR 2017. These laboratories offer a boost to
the domestic manufacturing sector by providing the required infrastructure for
testing the device depending on the project proposals and the technical support
provided by the National Health Systems Resource Centre, which is a technical
support organization governed by the health ministry.
●
Testing and evaluation
●
Functions as an appellate laboratory
●
Carry out function about medical devices that are specially
assigned by Central Government
The new rules were notified in the year 2017 on January 31 as
per the D&C act to regulate the manufacture, sale, import, and distribution
of all medical devices, which came into effect from January 1.2018.
As per the rule, Sipra labs in Telangana, Hyderabad, are
responsible for carrying out the test and evaluating some medical devices like
Copper –T, Sterile Hypodermic Needles Hypodermic Syringes, Blood Bags, condoms,
etc.
Star Imaging and Path Lab of West Delhi will evaluate
Bilirubin test, Reagents/ kits, Creatinine test reagent, Aspartate
Aminotransferase, Alanine Aminotransferase, Uric Acid test reagents, total protein
test reagents, along with Prothrombin time test reagents kits.
Alcatel Research Laboratories India Pvt Ltd, based in
Haryana, will make an evaluation of Sterilized surgical ligatures, sterilized
disposable devices, along sterilized surgical sutures.
Sree Chitra Tirunal Institute of medical science and
technology, Thiruvananthapuram, will make an evaluation of the cardiovascular
devices, Neuroprosthesis, and orthopedic implants.
The union health ministry is making plans to improve the
workforce at CDSCO for efficient licensing and execution activities to ensure
safety, best quality, and devices' overall performances.
Because when so many medical devices are under regulatory
control, it will lead to enhancement of workload. Therefore, a total of 754 CDSCO
officers and staff will be added to the already existing workforce, which has
119 regulatory and lab staff, before implementing the second phase.
The regulatory infrastructure, along with the manpower, must be strengthened for licensing and enforcement activities, according to the Drugs Technical Advisory Board report. It was also recommended by DTAB that all those five laboratories must get ready within a period of 5 years for testing several medical devices along with in-vitro diagnostics medical devices.
Go to know more information: Medical Device Regulation India | Drug product registration in India
Comments
Post a Comment
Please do not enter any spam link in the comment box